We hypothesized that simultaneous detection of antibodies against tumor‐associated glycans in combination with multiplex measurement of several tumor markers in patients’ serum could be significantly superior in early diagnostics of CRC as compared with the detection of just two tumor markers, CA 19–9 and CEA. Here, CEACAM5 is linked to colorectal carcinoma.